Home > Healthcare & Medical Devices > Anti-infectives Market

Anti-infectives Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI3868

Anti-Infectives Market size is set to gain notable proceeds from 2021 to 2027 owing to the rise in the number of R&D initiatives and product approvals for drug development. The rising instances of infectious diseases have led to higher levels of health consciousness among consumers. The growing assistance by governmental and non-governmental organizations through funding will further favor the market growth.

Anti-infectives are mainly drugs or agents that resist or inhibit the spread of an infectious organism through killing. The rise in the number of primary care clinics and hospitals together with the ease of access to diagnostics will augment the market expansion.


The anti-bacterial segment will showcase substantial proceeds driven by their high prescription. Apart from being employed as medicines for humans or animals, anti-bacterials are incorporated health and skincare products, soaps, detergents, and household cleaners. Increasing utility to disinfect surfaces and to potentially weed out harmful bacteria will amplify the product demand spurt.

The oral route of administration will expand with the rising obligation for reduced hospital stays. Limited complications and the lower usage of central lines for intravenous drug administration are some of the benefits of oral administrations. The mount in product developments will also favor the market progression.

The HIV Infections segment in the market will observe inclination through 2027 ascribing to the increasing focus on the prevention, diagnosis, and treatment of the disease.

The adoption of anti-infectives in hospitals is expected to rise, attributed to the globally rising instances of hospitalizations. The provision of insurance policies, quick reimbursement, and easy access to enhanced patient care and treatment in these facilities will act as significant contributors to the industry progression.

North America anti-infectives market size is poised to expand due to the presence of key manufacturers and robust healthcare infrastructure in the region. The higher prevalence of infectious diseases along with the rising product awareness among clinicians has paved the path for numerous government initiatives as well as favorable reimbursement policies. The increasing expenditure on expensive drugs, mount in the number of private partnership projects, and the significant developments in the healthcare sector are some factors influencing the industry growth.


Pfizer, Johnson & Johnson, Merck (E. Merck KG), GlaxoSmithKline, Roche, Novartis, Astra Zeneca, Sanofi, Abbott Laboratories, and Wockhardt (Humuza Consultants) are major anti-infectives market players.


These renowned firms are keen on inorganic strategic team-ups, like acquisitions, and partnerships to enhance their global presence. They are also working on novel product launches and capacity expansions to proliferate their offerings and customer base.


For instance, in April 2021, Pfizer acquired Amplyx Pharmaceuticals, a leading U.S.-based company, in a bid to expand its anti-infectives pipeline. The deal also helped the firm obtain the latter’s lead compound, Fosmanogepix (APX001), used in the treatment of invasive fungal infections.

In another instance, in June 2020, Sanofi joined hands with Evotec, a major drug discovery firm, to sign an agreement to transfer its anti-infectives unit to the latter company for $70 million.


Effect of the COVID-19 outbreak on the anti-infectives market outlook

The COVID-19 pandemic made way for significant turmoil in the global economy as it projected crippling challenges on several industries across the world. However, the industry demand witnessed a substantial boom considering their therapeutic potential against COVID-19. The higher repurposing of several anti-infectives drugs, including nitazoxanide, doxycycline, and azithromycin helped in improving the symptoms in mild as well as moderately infected patients.


Market research report on anti-infectives includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, by Type

  • Antibacterial
  • Antiviral
  • Antifungal

Market, by Range

  • Narrow Spectrum
  • Broad Spectrum

Market, by Distribution Channel

  • Hospital
  • Retail Pharmacies
  • Online Pharmacies

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • Saudi Arabia
    • South Africa

What Information does this report contain?

Historical data coverage: 2017 to 2021; Growth Projections: 2022 to 2028.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Budget constraints? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability